Loring Wolcott & Coolidge Fiduciary Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-505	Closed	-$37K	–	776
2019 Q1	$37K	Hold	505	–	–	﹤0.01%	435
2018 Q4	$29K	Hold	505	–	–	﹤0.01%	468
2018 Q3	$39K	Hold	505	–	–	﹤0.01%	446
2018 Q2	$34K	Hold	505	–	–	﹤0.01%	465
2018 Q1	$26K	Hold	505	–	–	﹤0.01%	512
2017 Q4	$27K	Buy	+505	New	+$29.5K	﹤0.01%	487

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's SGEN Position: Q2 2019 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q2 2019, closing a stake of 505 shares — an estimated $37K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in SGEN in Q4 2017 and held it in 6 quarters. The position peaked at $39K in Q3 2018. 324 funds tracked by Wall St. Rank hold SGEN as of Q2 2019.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Seagen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 505 Seagen Inc. Common Stock shares in Q2 2019, an estimated $37K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 6 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Seagen Inc. Common Stock position peaked at $39K in Q3 2018.
324 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2019.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.